# SPIRONOLACTONE
> **ANDA215572** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2023-09-05
## Drug
- **FDA Application Number:** ANDA215572
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SPIRONOLACTONE
- **Generic name:** SPIRONOLACTONE
- **Active ingredients:** SPIRONOLACTONE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals NY LLC
- **First approval:** 2023-09-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215572)
---
*AI Analytics · CC0 1.0*